Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Pediatric Neurology

Symptoms and the Path of Progression

At a Glance

NESCAV syndrome can change as a child grows: early low muscle tone and developmental delay may be followed by stiffness, balance, vision, speech, or mobility problems. The pattern varies, and sudden loss of skills or new concerning symptoms needs medical evaluation.

Understanding the path of NESCAV syndrome requires a shift in how we think about neurological conditions. Unlike a “static” condition like cerebral palsy, where the initial brain injury does not get worse over time, NESCAV is neurodegenerative [1]. This means that while your child will continue to learn and grow, the underlying condition can cause new symptoms to appear or existing ones to change as they get older [2].

It is important to note that the statistics presented below come from cohort studies of the broader KAND spectrum. They highlight common trends but cannot predict your individual child’s course. Some children will have many of these symptoms, while others may have only a few.

Early Signs in Infancy

For many families, the first signs appear in the first year of life [3]. These early indicators often include:

  • Infantile Hypotonia: This is low muscle tone, often called “floppiness.” It affects many children in the KAND spectrum [2]. You might notice your baby has trouble holding their head up or feels “heavy” in your arms.
  • Global Developmental Delay: Most children will reach milestones like sitting, crawling, and babbling later than their peers [2].
  • Vision Challenges: Early problems often involve Optic Nerve Atrophy (a weakening of the cable connecting the eye to the brain) or Cortical Visual Impairment (where the eyes work, but the brain struggles to process the image) [4][3].

The Motor Evolution: From “Floppy” to “Stiff”

One of the most distinct features of NESCAV is how muscle tone changes over time. Many children begin with low tone (hypotonia) but gradually develop high tone, or spasticity [2].

  • Spastic Paraparesis: This is a progressive stiffness and weakness, typically in the legs. Spasticity often becomes more pronounced as children get older [2].
  • Changes in Walking: While some children learn to walk independently, the progressive nature of spasticity and ataxia (problems with balance and coordination) means that some may eventually need more support, such as walkers or wheelchairs, to stay mobile [2].

Changes in the Brain and Nervous System

Doctors use MRIs to track how the condition affects the brain. A common finding is Cerebellar Atrophy, which is a shrinking of the part of the brain that helps control balance [5].

  • Progression on Imaging: On serial MRIs taken years apart, doctors may see that this atrophy progresses or that the cerebral hemispheres (the larger parts of the brain) also show signs of volume loss [1][6].
  • Peripheral Neuropathy: Some children develop damage to the nerves outside the brain and spinal cord, which can cause numbness, tingling, or further weakness in the hands and feet [7].

Communication and Speech

Communication is a major area of focus. A vast majority of children assessed in KAND cohorts experience some form of language impairment [8].

  • Dysarthria: This is a motor speech disorder where the muscles used for speech are weak or difficult to control, making words sound slurred [8].
  • AAC Use: Because speaking can be physically exhausting or difficult, many families use Augmentative and Alternative Communication (AAC) [8]. This can range from simple picture boards to high-tech speech-generating devices.

Assessing Decline vs. True Loss of Skills

It is critical to distinguish between a “relative decline” and a true loss of skills. If your child’s developmental standard scores drop, it may simply mean the gap between their abilities and those of same-age peers is widening, even as they continue to learn. However, a true loss of a previously mastered skill (like losing the ability to speak a word or walk a certain way) is a significant change.

If your child experiences sudden skill loss, new weakness, choking, or staring spells and unusual movements (which could be seizures, affecting some children with KAND), this is not just “expected progression” and requires clinical evaluation [8][9].

Common questions in this guide

What are the first signs of NESCAV syndrome in a child?
Early signs often appear during the first year and can include low muscle tone, delayed sitting or crawling, and difficulty babbling. Some children also have optic nerve problems or difficulty processing visual information even when the eyes themselves work.
Does NESCAV syndrome progress as a child grows?
Yes. NESCAV is described as a neurodegenerative condition, so new symptoms may appear or existing abilities may change over time. Patterns reported in groups of children cannot predict exactly what will happen for one child.
Can low muscle tone change to stiffness in NESCAV syndrome?
Many children start with low muscle tone and later develop stiffness, especially in the legs, along with balance and coordination problems. Some may eventually need a walker or wheelchair, while others retain more independent mobility.
What communication problems can NESCAV syndrome cause?
Communication difficulties may include delayed language and dysarthria, a problem controlling the muscles used for speech. Speech may be hard to understand or tiring, and augmentative and alternative communication, such as picture boards or speech-generating devices, may help a child express needs.
When should new symptoms in a child with NESCAV syndrome be evaluated?
Sudden loss of a mastered skill, new weakness, choking, or staring spells and unusual movements should be discussed promptly with the child's clinician. Staring spells or unusual movements may be seizures, so the clinician may consider an evaluation or video-EEG.
What can an MRI show in NESCAV syndrome?
Serial MRIs may show shrinkage of the cerebellum, the part of the brain involved in balance, and sometimes volume loss in larger areas of the brain. The child's neurologist interprets these findings alongside development, movement, vision, and examination results.

Get notified when new evidence is published on NESCAV syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Long-term Observation of a Japanese Patient with a Multiple-system Neurodegenerative Disorder with a Uniallelic de novo Missense Variant in KIF1A.

    Nakamura K, Yoshinaga T, Kodaira M, et al.

    Internal medicine (Tokyo, Japan) 2023; (62(20)):3047-3051 doi:10.2169/internalmedicine.1184-22.

    PMID: 36889712
  2. 2

    KIF1A-Associated Neurological Disorder (KAND): Spectrum of Movement and Motor Disorders in a Cohort of 51 Patients.

    Bernardi K, Ribeiro G, Battaglia N, et al.

    Movement disorders : official journal of the Movement Disorder Society 2026; (41(10)):2737-2744 doi:10.1002/mds.70420.

    PMID: 42500835
  3. 3

    [KIF1A gene-associated neurological disease: the correlation between genotype and phenotype].

    Ortiz-Ortigosa A, Calvo-Medina R, Ruiz-García C, et al.

    Revista de neurologia 2023; (77(6)):141-145 doi:10.33588/rn.7706.2023185.

    PMID: 37668235
  4. 4

    Ophthalmic Findings in the KIF1A-Associated Neurologic Disorder (KAND).

    Abdelhakim AH, Brodie SE, Chung WK

    American journal of ophthalmology 2024; (268()):247-257 doi:10.1016/j.ajo.2024.06.025.

    PMID: 39009236
  5. 5

    Heterogeneity of comprehensive clinical phenotype and longitudinal adaptive function and correlation with computational predictions of severity of missense genotypes in KIF1A-associated neurological disorder.

    Sudnawa KK, Li W, Calamia S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2024; (26(8)):101169 doi:10.1016/j.gim.2024.101169.

    PMID: 38785164
  6. 6

    Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement.

    Hotchkiss L, Donkervoort S, Leach ME, et al.

    Journal of child neurology 2016; (31(9)):1114-9 doi:10.1177/0883073816639718.

    PMID: 27034427
  7. 7

    The Novel KIF1A Missense Variant (R169T) Strongly Reduces Microtubule Stimulated ATPase Activity and Is Associated With NESCAV Syndrome.

    Aguilera C, Hümmer S, Masanas M, et al.

    Frontiers in neuroscience 2021; (15()):618098 doi:10.3389/fnins.2021.618098.

    PMID: 34121983
  8. 8

    Understanding speech and language in KIF1A-associated neurological disorder.

    Morison LD, Vogel AP, Christodoulou J, et al.

    European journal of human genetics : EJHG 2026; (34(1)):78-89 doi:10.1038/s41431-025-01867-0.

    PMID: 40379967
  9. 9

    Integrating Single-Molecule Variant Phenotyping with Clinical Features Predicts Outcomes in KIF1A-Associated Neurological Disorder.

    Rao L, Li W, Waxler J, et al.

    medRxiv : the preprint server for health sciences 2026; doi:10.64898/2026.09.10.26362467.

    PMID: 42779870

This page is for informational purposes only and does not constitute medical advice. Your child's neurologist and care team should interpret symptoms, MRI findings, and possible seizures.